OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (6)

  1. Hyery Kim. Recent advances in the treatment of pediatric acute leukemia. J Korean Med Assoc 2016;59:690
    https://doi.org/10.5124/jkma.2016.59.9.690
  2. Alaa Koleilat, James B. Smadbeck, Cinthya J. Zepeda‐Mendoza, Cynthia M. Williamson, Beth A. Pitel, Crystal L. Golden, Xinjie Xu, Patricia T. Greipp, Rhett P. Ketterling, Nicole L. Hoppman, Jess F. Peterson, Christine J. Harrison, Yassmine M. N. Akkari, Karen D. Tsuchiya, Mary Shago, Linda B. Baughn. Characterization of unusual iAMP21 B‐lymphoblastic leukemia (iAMP21‐ALL) from the Mayo Clinic and Children's Oncology Group. Genes Chromosomes & Cancer 2022;61:710
    https://doi.org/10.1002/gcc.23084
  3. Anju Vijayan, Minu Singh, Deepak Bansal, Sreejesh Sreedharanunni, Neelam Varma, Man Updesh Singh Sachdeva, Prateek Bhatia. iAMP21 screening by MLPA assay: Need for identification of characteristic pattern of amplification in addition to mean probe ratios to avoid false positivity. Int J Lab Hematology 2020;42
    https://doi.org/10.1111/ijlh.13085
  4. Ewa Wrona, Marcin Braun, Agata Pastorczak, Joanna Taha, Monika Lejman, Jerzy Kowalczyk, Wojciech Fendler, Wojciech Młynarski. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL. J Appl Genetics 2019;60:347
    https://doi.org/10.1007/s13353-019-00509-8
  5. Amal Abd Elhameed, Rasha El-Gamal, Esraa Hasan, Reham Mohamed Nagy. Intrachromosomal amplification of chromosome 21 in Egyptian pediatric B-lineage acute lymphoblastic leukemia: a hospital-based observational study. EGJH 2023;48:169
    https://doi.org/10.4103/ejh.ejh_57_22
  6. Adrián Montaño, Maribel Forero-Castro, Darnel Marchena-Mendoza, Rocío Benito, Jesús María Hernández-Rivas. New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update. Cancers 2018;10:110
    https://doi.org/10.3390/cancers10040110
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd